Amanote Research
Register
Sign In
Matched-Pair Analysis to Compare the Outcomes of a Second Salvage Auto-SCT to Systemic Chemotherapy Alone in Patients With Multiple Myeloma Who Relapsed After Front-Line Auto-SCT
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2012.164
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
September 3, 2012
Authors
H-Y Yhim
K Kim
J S Kim
H J Kang
J-A Kim
C-K Min
S H Bae
E Park
D-H Yang
C Suh
M K Kim
Y-C Mun
H S Eom
H J Shin
H-J Yoon
J H Kwon
J H Lee
Y S Kim
S-S Yoon
J-Y Kwak
Publisher
Springer Science and Business Media LLC
Related search
Incident Hyperglycemia, Parenteral Nutrition Administration and Adverse Outcomes in Patients With Myeloma Admitted for Initial Auto-SCT
Bone Marrow Transplantation
Transplantation
Hematology
A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Auto-SCT for AML in Second Remission: CALGB Study 9620
Bone Marrow Transplantation
Transplantation
Hematology
Prognostic Factors and Outcome in Relapsed Multiple Myeloma After Nonmyeloablative Allo-Sct: A Single Center Experience
Bone Marrow Transplantation
Transplantation
Hematology
Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network
Bone Marrow Transplantation
Transplantation
Hematology
Small-Sized Clone of T Cells in Multiple Myeloma Patient After Auto-Sct: T-LGL Leukemia Type or Clonal T-Cell Aberration?
Case Reports in Hematology
Primary Central Nervous System Lymphoma: Implication of High-Dose Chemotherapy Followed by Auto-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Semi-Ambulatory Autologous Peripheral Blood SCT in 79 Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
